Steven M Opal Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2017	Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia.
6/2015	Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers.
5/2013	The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.
11/2011	Immunomodulatory therapy for sepsis: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Opal Research Topics

Disease

78	Sepsis (Septicemia) 02/2021 - 01/2002
28	Infections 01/2020 - 03/2003
25	Septic Shock (Toxic Shock Syndrome) 02/2021 - 04/2002
15	Inflammation (Inflammations) 01/2020 - 01/2003
7	Pneumonia (Pneumonitis) 01/2020 - 03/2008
7	Critical Illness (Critically Ill) 04/2011 - 05/2002
6	Bacterial Infections (Bacterial Infection) 12/2016 - 03/2003
6	Human Influenza (Influenza) 01/2016 - 05/2008
5	Hemorrhage 01/2019 - 02/2006
4	Bacteremia 01/2017 - 03/2003
4	Pneumococcal Pneumonia 04/2016 - 04/2010
4	Disseminated Intravascular Coagulation 02/2016 - 01/2004
4	Fever (Fevers) 02/2016 - 11/2003
4	Anthrax 04/2012 - 11/2004
3	Endotoxemia 02/2021 - 03/2003
3	Peritonitis 04/2016 - 03/2008
3	Hypovolemia 02/2016 - 02/2013
3	Shock 07/2014 - 01/2009
3	Hypoxia (Hypoxemia) 02/2013 - 12/2008
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2013 - 01/2004
3	Venous Thrombosis (Deep-Vein Thrombosis) 02/2013 - 05/2006
3	Communicable Diseases (Infectious Diseases) 03/2008 - 11/2004
3	Listeriosis (Listeria Infection) 01/2007 - 12/2005
2	COVID-19 10/2020 - 01/2020
2	Edema (Dropsy) 10/2019 - 01/2011
2	Coinfection 01/2019 - 03/2015
2	Hypotension (Low Blood Pressure) 06/2016 - 01/2006
2	Gram-Negative Bacterial Infections 03/2015 - 02/2015
2	Neutropenia 02/2015 - 01/2003
2	Low Cardiac Output 02/2013 - 02/2013
2	Ulcer 02/2013 - 02/2013

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2006
14	EndotoxinsIBA 02/2021 - 01/2002
13	CytokinesIBA 01/2019 - 04/2003
10	Protein CIBA 07/2014 - 01/2003
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2003
6	AnticoagulantsIBA 10/2019 - 01/2003
6	VaccinesIBA 10/2014 - 11/2003
5	AntibodiesIBA 09/2016 - 11/2003
5	LipopolysaccharidesIBA 10/2014 - 11/2003
5	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2014 - 04/2002
5	Proteins (Proteins, Gene)FDA Link 06/2013 - 07/2005
5	AntithrombinsIBA 10/2011 - 05/2002
5	Interleukin-6 (Interleukin 6)IBA 01/2010 - 01/2006
5	Heparin (Liquaemin)FDA LinkGeneric 01/2009 - 05/2002
4	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 11/2011
4	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2013 - 01/2004
4	LigandsIBA 06/2012 - 12/2005
4	Receptor for Advanced Glycation End ProductsIBA 06/2012 - 01/2007
4	AntigensIBA 01/2011 - 08/2005
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2006
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2019 - 02/2013
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018 - 10/2011
3	Anti-Infective Agents (Microbicides)IBA 04/2016 - 03/2003
3	Viral RNAIBA 01/2016 - 05/2008
3	RNA (Ribonucleic Acid)IBA 01/2016 - 05/2008
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2014 - 11/2003
3	SuperantigensIBA 06/2013 - 12/2008
3	ExotoxinsIBA 06/2013 - 11/2004
3	eritoranIBA 03/2013 - 01/2010
3	Vasopressins (Vasopressin)IBA 02/2013 - 01/2010
3	drotrecogin alfa activated (Xigris)FDA Link 10/2011 - 07/2003
3	Monoclonal AntibodiesIBA 05/2011 - 03/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 01/2006
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2019 - 01/2018
2	ThrombomodulinIBA 10/2019 - 01/2019
2	Imipenem FDA Link 01/2019 - 06/2014
2	IMT504IBA 03/2017 - 02/2015
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2016 - 01/2006
2	Interleukin-1 (Interleukin 1)IBA 02/2016 - 01/2006
2	Peptides (Polypeptides)IBA 03/2015 - 06/2013
2	AB103IBA 03/2015 - 06/2013
2	AutoantibodiesIBA 09/2014 - 08/2013
2	Antiviral Agents (Antivirals)IBA 05/2013 - 01/2013
2	Insulin (Novolin)FDA Link 02/2013 - 02/2013
2	Blood Glucose (Blood Sugar)IBA 02/2013 - 02/2013
2	Neuromuscular Blocking AgentsIBA 02/2013 - 02/2013
2	Vasodilator Agents (Vasodilators)IBA 02/2013 - 02/2013
2	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 02/2013 - 02/2013
2	Crystalloid SolutionsIBA 02/2013 - 02/2013
2	Hemoglobins (Hemoglobin)IBA 02/2013 - 02/2013
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 02/2013
2	Oxygen (Dioxygen)IBA 02/2013 - 02/2013
2	Epinephrine (Adrenaline)FDA LinkGeneric 02/2013 - 02/2013
2	AlbuminsIBA 02/2013 - 02/2013
2	Dopamine (Intropin)FDA LinkGeneric 02/2013 - 02/2013
2	Dobutamine FDA LinkGeneric 02/2013 - 02/2013

Therapy/Procedure

41	Therapeutics 02/2021 - 03/2003
8	Critical Care (Surgical Intensive Care) 02/2016 - 04/2003
7	Ligation 01/2019 - 12/2005
7	Punctures 01/2019 - 12/2005
6	Resuscitation 02/2013 - 01/2004
3	Oral Administration 10/2014 - 12/2005
3	Drug Therapy (Chemotherapy) 01/2014 - 01/2003
2	Precision Medicine 02/2021 - 04/2017
2	Continuous Renal Replacement Therapy 02/2013 - 02/2013
2	Renal Dialysis (Hemodialysis) 02/2013 - 02/2013
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 02/2013 - 02/2013
2	Cannula 02/2013 - 02/2013